Unspecified Galliprant

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death Rate

Active Ingredients

Unspecified Galliprant

Administration Routes

OralUnknown

Species Affected

Dog 12

Most Affected Breeds

Shepherd Dog - Australian 4

Retriever - Golden 1

Retriever - Labrador 1

Setter - English 1

Terrier - Jack Russell 1

Terrier (unspecified) 1

Spaniel (unspecified) 1

Bichon Frise 1

Shepherd Dog - German 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 6

Ataxia 3

Hind limb paralysis 3

Stiffness limb 2

Painful defecation 2

Weight loss 2

Restlessness 2

Unable to rise 1

Anorexia 1

Fever 1

Paresis 1

Abnormal electrocardiogram (ECG) 1

Outcome Breakdown

Outcome Unknown

7 (58.3%)

Ongoing

3 (25.0%)

Recovered/Normal

2 (16.7%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.